Safety and efficacy of B7-H3 targeting CAR-T cell therapy for patients with recurrent GBM

被引:0
|
作者
Zhang, Yang
Feng, Rui
Chi, Xiaohan
Xian, Na
Chen, Xianzhen
Huang, Na
Zhang, Yu
Zhang, Kangna
Zhang, Jindong
Chen, Lieping
Ji, Nan
Huang, Gangxiong
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China
[2] Fuzhou Tcelltech Biol Sci & Technol Inc, Fuzhou, Peoples R China
[3] Yale Canc Ctr, New Haven, CT USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2062
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [31] T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting
    Xin Sun
    Yang Yu
    Li Ma
    Xin Xue
    Zhenkui Gao
    Juan Ma
    Man Zhang
    Investigational New Drugs, 2020, 38 : 722 - 732
  • [33] T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting
    Sun, Xin
    Yu, Yang
    Ma, Li
    Xue, Xin
    Gao, Zhenkui
    Ma, Juan
    Zhang, Man
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (03) : 722 - 732
  • [34] CAR-T Cell Therapy: the Efficacy and Toxicity Balance
    Chohan, Karan L.
    Siegler, Elizabeth L.
    Kenderian, Saad S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (02) : 9 - 18
  • [35] Safety of CAR-T Cell Therapy in Asymptomatic Patients with Positive Respiratory Viral Testing Prior to CAR-T Infusions
    Muenzen, Reid M.
    Chong, Emeline R.
    Therwhanger, Dylan
    Landsburg, Daniel J.
    Nasta, Sunita D.
    Svoboda, Jakub
    Barta, Stefan K.
    Hughes, Mitchell E.
    Weber, Elizabeth
    Ruella, Marco
    Frey, Noelle V.
    Porter, David L.
    Schuster, Stephen J.
    Chong, Elise A.
    BLOOD, 2023, 142
  • [36] Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
    Yang, Meijia
    Tang, Xin
    Zhang, Zongliang
    Gu, Lei
    Wei, Heng
    Zhao, Shasha
    Zhong, Kunhong
    Mu, Min
    Huang, Cheng
    Jiang, Caiying
    Xu, Jianguo
    Guo, Gang
    Zhou, Liangxue
    Tong, Aiping
    THERANOSTICS, 2020, 10 (17): : 7622 - 7634
  • [37] CAR-T Cell Therapy: the Efficacy and Toxicity Balance
    Karan L. Chohan
    Elizabeth L. Siegler
    Saad S. Kenderian
    Current Hematologic Malignancy Reports, 2023, 18 : 9 - 18
  • [38] Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies
    Manni, Simona
    Del Bufalo, Francesca
    Merli, Pietro
    Silvestris, Domenico Alessandro
    Guercio, Marika
    Caruso, Simona
    Reddel, Sofia
    Iaffaldano, Laura
    Pezzella, Michele
    Di Cecca, Stefano
    Sinibaldi, Matilde
    Ottaviani, Alessio
    Quadraccia, Maria Cecilia
    Aurigemma, Mariasole
    Sarcinelli, Andrea
    Ciccone, Roselia
    Abbaszadeh, Zeinab
    Ceccarelli, Manuela
    De Vito, Rita
    Lodi, Maria Chiara
    Cefalo, Maria Giuseppina
    Mastronuzzi, Angela
    De Angelis, Biagio
    Locatelli, Franco
    Quintarelli, Concetta
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [39] Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies
    Simona Manni
    Francesca Del Bufalo
    Pietro Merli
    Domenico Alessandro Silvestris
    Marika Guercio
    Simona Caruso
    Sofia Reddel
    Laura Iaffaldano
    Michele Pezzella
    Stefano Di Cecca
    Matilde Sinibaldi
    Alessio Ottaviani
    Maria Cecilia Quadraccia
    Mariasole Aurigemma
    Andrea Sarcinelli
    Roselia Ciccone
    Zeinab Abbaszadeh
    Manuela Ceccarelli
    Rita De Vito
    Maria Chiara Lodi
    Maria Giuseppina Cefalo
    Angela Mastronuzzi
    Biagio De Angelis
    Franco Locatelli
    Concetta Quintarelli
    Nature Communications, 14
  • [40] Possible Factors on Efficacy and Safety of CAR-T Therapy in Relapsed or Refractory Aggressive B-Cell Lymphoma
    Huang, Haiwen
    Jiang, Yibin
    Jin, Zhengming
    Li, Caixia
    Wu, Depei
    BLOOD, 2018, 132